Riskpilot← Back to searchSign inGet full accessJSH BIOTECH ApS
APSActiveCVR 25220129Vingårds Alle 39Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2000— employees
Revenue 2025
DKK 620K
+219% vs 2024
EBITDA margin
100.0%
+219% vs 2024
Equity ratio
95.0%
Financial strength
Net profit 2025
DKK 3,4M
+195% vs 2024
| Revenue | DKK 620K | +219% |
| EBITDA | DKK 620K | +219% |
| Net profit | DKK 3,4M | +195% |
| Total assets | DKK 7M | +4% |
| Equity | DKK 6,7M | +97% |
| Employees | — | — |
Legal name
JSH BIOTECH ApS
CVR number
25220129
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
1. februar 2000
Share capital
DKK 330.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af 1 direktør
Company purpose
Selskabets formål er alene at udøve formueadministration.
Address
Vingårds Alle 39
Phone
+4540835488
Email
haurum@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3 | 40 | -3 | -17 | -7 | -8 | -14 | 266 | 578 | 649 | 341 | 301 | 194 | 620 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3 | 40 | -3 | -17 | -7 | -8 | -14 | 266 | 578 | 649 | 341 | 301 | 194 | 620 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | 40 | -3 | -17 | -7 | -8 | -14 | 266 | 578 | 649 | 341 | 301 | 194 | 620 |
| Net financials | 0 | 137 | 123 | 116 | -28 | -24 | 57 | 304 | 3.393 | 3.298 | -3.596 | -1.624 | 960 | 2.790 |
| Profit before tax | -3 | 177 | 120 | 100 | -35 | -32 | 43 | 569 | 3.971 | 3.947 | -3.255 | -1.323 | 1.154 | 3.410 |
| Tax | -0 | 8 | 1 | 23 | -8 | -7 | 9 | 131 | 790 | 857 | -0 | -0 | -0 | -0 |
| Net profit | -3 | 169 | 119 | 77 | -27 | -25 | 34 | 438 | 3.181 | 3.090 | -3.255 | -1.323 | 1.154 | 3.410 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 224 | 406 | 751 | 601 | 554 | 528 | 875 | 1.933 | 9.139 | 10.147 | 7.851 | 5.588 | 6.724 | 7.003 |
| Equity | 207 | 376 | 496 | 573 | 546 | 520 | 554 | 992 | 4.173 | 7.151 | 3.781 | 2.340 | 3.377 | 6.652 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 | 30 | 255 | 28 | 9 | 8 | 321 | 941 | 4.966 | 2.996 | 4.070 | 3.248 | 3.348 | 352 |
| Total debt | 17 | 30 | 255 | 28 | 9 | 8 | 321 | 941 | 4.966 | 2.996 | 4.070 | 3.248 | 3.348 | 352 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122025
Equity ratio
95.0%
This company
38.2%
Market median
+149% vs market
20122025
Return on equity
51.3%
This company
18.4%
Market median
+179% vs market
20122025
Net profit margin
549.7%
This company
8.1%
Market median
+6686% vs market
20122025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20122025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Audit | Audit | 2000 | — | — |
VC Management | Management | 2000 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JSH BIOTECH ApS 
ARK Invest IVSBoard members of JSH BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl-Alfred Brylle | Audit | 0 companies |
| Victor Christoffersen | Management | 0 companies |